Treatment options in irritable bowel syndrome
- 31 August 2004
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 18 (4) , 773-786
- https://doi.org/10.1016/j.bpg.2004.04.008
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Increased platelet stores of 5-hydroxytryptamine (5-HT) in female patients with diarrhoea predominant irritable bowel syndrome (IBS)Gastroenterology, 2001
- CilansetronDrugs of the Future, 1999
- Evidence of inflammatory pathogenesis in post-infectious irritable bowel syndromeGastroenterology, 1998
- New Drugs in the Management of the Irritable Bowel SyndromeDrugs, 1998
- A Double-Blind Placebo-Controlled Trial with Loperamide in Irritable Bowel SyndromeScandinavian Journal of Gastroenterology, 1996
- Effect of a tricyclic antidepressant on small intestinal motility in health and diarrhea-predominant irritable bowel syndromeDigestive Diseases and Sciences, 1995
- The difficult patientEuropean Journal of Gastroenterology & Hepatology, 1994
- 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake.Gut, 1994
- Effect of a 5HT3‐antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 1993
- Brief Psychotherapy with Patients with Refractory Irritable Bowel SyndromeBritish Journal of Psychotherapy, 1991